Search research articles
Contact Us
Filters
Showing results (41-50 of 174) with videos related to
Page
of 18
Sort By:
European Journal of Haematology
|
November 29, 2016
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma
Massimo Offidani, Laura Corvatta, Sara Bringhen, et al.
Cancer
|
June 28, 2007
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy
Antonio Palumbo, Sara Bringhen, Patrizia Falco, et al.
Haematologica
|
September 4, 2025
Peripheral monoclonal plasmacytosis in infective endocarditis: a tangled web
Giuseppe Bertuglia, Enrico Amaducci, Davide Stella, et al.
Nature Reviews. Disease Primers
|
July 21, 2017
Multiple myeloma
Shaji K Kumar, Vincent Rajkumar, Robert A Kyle, et al.
Cancers
|
April 14, 2025
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
Cancers
|
August 14, 2025
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. <i>Cancers</i> 2025, <i>17</i>, 1168
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
Annals of Hematology
|
January 8, 2025
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies
Luciano J Costa, Francesca Gay, Ola Landgren, et al.
Journal of Clinical Medicine
|
September 30, 2020
Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma
María-Victoria Mateos, Joan Bladé, Sara Bringhen, et al.
Leukemia & Lymphoma
|
November 21, 2008
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates
Vittorio Montefusco, Francesca Gay, Francesco Spina, et al.
Oncotargets and Therapy
|
September 3, 2025
The Role of CELMoD Agents in Multiple Myeloma
Niels W C J van de Donk, Nizar J Bahlis, Charlotte Pawlyn, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 174) with videos related to
Sort By:
Page
of 18
European Journal of Haematology
|
November 29, 2016
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma
Massimo Offidani, Laura Corvatta, Sara Bringhen, et al.
Cancer
|
June 28, 2007
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy
Antonio Palumbo, Sara Bringhen, Patrizia Falco, et al.
Haematologica
|
September 4, 2025
Peripheral monoclonal plasmacytosis in infective endocarditis: a tangled web
Giuseppe Bertuglia, Enrico Amaducci, Davide Stella, et al.
Nature Reviews. Disease Primers
|
July 21, 2017
Multiple myeloma
Shaji K Kumar, Vincent Rajkumar, Robert A Kyle, et al.
Cancers
|
April 14, 2025
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
Cancers
|
August 14, 2025
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. <i>Cancers</i> 2025, <i>17</i>, 1168
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
Annals of Hematology
|
January 8, 2025
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies
Luciano J Costa, Francesca Gay, Ola Landgren, et al.
Journal of Clinical Medicine
|
September 30, 2020
Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma
María-Victoria Mateos, Joan Bladé, Sara Bringhen, et al.
Leukemia & Lymphoma
|
November 21, 2008
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates
Vittorio Montefusco, Francesca Gay, Francesco Spina, et al.
Oncotargets and Therapy
|
September 3, 2025
The Role of CELMoD Agents in Multiple Myeloma
Niels W C J van de Donk, Nizar J Bahlis, Charlotte Pawlyn, et al.
Page
of 18